In our study, we also observed increased expression of ROMO1 in diabetic kidney which was mitigated following GYY treatment suggesting that the effect of GYY in ROS mitigation was in part due to inhibition of ROMO1 expression (Fig. 1D and F). This evidence concerns the gene ROMO1 and diabetes mellitus.